potentially a multiple of the current price, page-2

This is the 3 report they have done in the last 12 months. all quickview not full reports.



One of the analysts is a ex pfizer a way back ( then again so is half the industry been at them or glaxo in their career)

http://www.edisoninvestmentresearch.com/about/meet-the-team#js

Analyst
Franc Gregori

Franc is a pharmacist who started his career with Boots, Eli Lilly and Pfizer before moving into the City as an analyst. He has worked with Robert Fleming, BZW and BNP Paribas, where he was involved in a number of major transactions. He joined Edison’s healthcare team from Charles Stanley, where he focused his coverage on small- and mid-cap life sciences stocks. Franc gained his pharmaceutical qualifications from the Welsh School of Pharmacy and King’s College London. He has an MBA from Cranfield and the University of Washington.